We’re the Australian Biotech Platform Translating Cellular Science into Regulated Longevity Solutions for Global Markets
Longevity Life Sciences (LLS) is pioneering the future of evidence-based longevity. As an integrated biotech company, LLS unites research, innovation, and commercialisation to bridge the gap between scientific discovery and market application.
A leader in NAD+ science, Longevity Life Sciences operates at the intersection of nutraceuticals, pharmaceuticals, and skincare science, translating cellular research into regulated, real-world applications.
LLS operates as a vertically integrated longevity biotech company, combining a dedicated research institute, advanced ingredient innovation, and commercial B2B and DTC pathways.
This ecosystem bridges the full continuum from scientific discovery to clinical validation and real-world application, ensuring every new innovation is evidence-based, regulatory-ready, and commercially scalable.
Our Scientific & Medical Advisory Board
Our Research Partners
Anchored by the newly established Longevity Life Sciences Research Institute and its partnerships with the University of Sydney and NICM, LLS is poised to produce world-first, GCP-compliant clinical evidence—advancing its position as a leader in credible, science-driven longevity innovation.
Leading the Global Shift Toward Evidence-Based Longevity Solutions to Increase Healthspan
Pioneering the Future of Longevity Science
LLS is helping to shape a new era of longevity science built on evidence, not opinion. As a pioneering Australian biotech company, it is leading the global shift toward clinically proven, preventative health solutions.
